“…Studies using CAR-null mice have demonstrated that CAR activation is an essential requirement for liver tumour development via a nongenotoxic mode of action, apparently through the induction of cell proliferation and suppression of apoptosis (Yamamoto et al, 2004;Huang et al, 2005). Indeed, CAR activation is associated with the increased or decreased expression of a large set of cell cycle regulators, including Cyclin D1, Mdm2, cMyc, Gadd45β, Cdkn1a, and others (Ledda- Columbano et al, 2003;Columbano et al, 2005;Yamamoto and Negishi, 2008;Yamamoto et al, 2010;Huang et al, 2005;Blanco-Bose et al, 2008;Kazantseva et al, 2013Kazantseva et al, , 2014. The promitogenic protein cMyc has been implicated in various aspects of liver proliferation.…”